Page last updated: 2024-08-25

rosiglitazone and Heritable Pulmonary Arterial Hypertension

rosiglitazone has been researched along with Heritable Pulmonary Arterial Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, F; Al-Hilal, TA; Alobaida, A; Hammouda, S; McMurtry, IF; Nozik-Grayck, E; Rashid, J; Stenmark, KR1
Dong, L; Han, D; Li, M; Li, S; Liu, L; Lu, J; Wang, G; Xie, X; Xu, J; Zhang, D; Zhang, Y1
Fang, X; Fung, ML; Huang, Y; Liu, Y; Mao, G; Shyy, JY; Tian, XY; Wang, N1

Other Studies

3 other study(ies) available for rosiglitazone and Heritable Pulmonary Arterial Hypertension

ArticleYear
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 06-28, Volume: 280

    Topics: Administration, Inhalation; Animals; Drug Carriers; Drug Compounding; Drug Liberation; Drug Repositioning; Familial Primary Pulmonary Hypertension; Humans; Hypoglycemic Agents; Male; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; PPAR gamma; Pulmonary Artery; Rats, Sprague-Dawley; Rosiglitazone; Treatment Outcome

2018
Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
    Life sciences, 2014, Mar-07, Volume: 98, Issue:1

    Topics: Animals; Blotting, Western; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Heme Oxygenase-1; Hypertension, Pulmonary; Hypoglycemic Agents; Immunoblotting; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2014
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:6

    Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Receptor, Serotonin, 5-HT2B; Rosiglitazone; Serotonin 5-HT2 Receptor Agonists; Thiazolidinediones; Thiophenes; Transcription Factor AP-1; Up-Regulation

2012